Linagliptin 5 mg and Metformin Hydrochloride (SR) 500 mg is a combination oral antidiabetic medication designed to manage type 2 diabetes mellitus effectively. Linagliptin, a DPP-4 inhibitor, works by increasing the levels of incretin hormones, which helps regulate blood sugar by increasing insulin release and decreasing glucagon levels in response to meals. Metformin Hydrochloride (Sustained Release) improves insulin sensitivity, reduces hepatic glucose production, and ensures gradual absorption for prolonged blood sugar control. Together, this combination helps maintain optimal glycemic control while reducing the risk of hypoglycemia. This tablet is recommended for adults with type 2 diabetes when diet, exercise, and monotherapy are insufficient for blood glucose management. It should be used under medical supervision, with regular monitoring of blood sugar levels and renal function.
